2018
DOI: 10.1038/s41551-018-0271-5
|View full text |Cite|
|
Sign up to set email alerts
|

A tissue-engineered scale model of the heart ventricle

Abstract: Laboratory studies of the heart use cell and tissue cultures to dissect heart function yet rely on animal models to measure pressure and volume dynamics. Here, we report tissue-engineered scale models of the human left ventricle, made of nanofibrous scaffolds that promote native-like anisotropic myocardial tissue genesis and chamber-level contractile function. Incorporating neonatal rat ventricular myocytes or cardiomyocytes derived from human induced pluripotent stem cells, the tissue-engineered ventricles ha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
201
1
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 179 publications
(223 citation statements)
references
References 84 publications
(115 reference statements)
5
201
1
1
Order By: Relevance
“…The dyn-EHT platform builds off of previous work from our laboratory and other investigators that have used primary, hESC and hiPSC derived cardiomyocytes to engineer functional cardiac tissues in vitro. Indeed, it is critical to acknowledge the important contributions to the field made by researchers using EHTs to model development and disease, and implementing more physiologic-like electromechanical conditioning to drive maturation (14,(16)(17)20,23,(25)(26)28,40,(61)(62)(63)(64). However, these 2D and 3D EHTs are generally isometrically constrained, which means they are unable to undergo significant fractional shortening or be stretched by preload.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The dyn-EHT platform builds off of previous work from our laboratory and other investigators that have used primary, hESC and hiPSC derived cardiomyocytes to engineer functional cardiac tissues in vitro. Indeed, it is critical to acknowledge the important contributions to the field made by researchers using EHTs to model development and disease, and implementing more physiologic-like electromechanical conditioning to drive maturation (14,(16)(17)20,23,(25)(26)28,40,(61)(62)(63)(64). However, these 2D and 3D EHTs are generally isometrically constrained, which means they are unable to undergo significant fractional shortening or be stretched by preload.…”
Section: Discussionmentioning
confidence: 99%
“…Further, strategies aimed at reducing the ventricular wall stress by integrating a temporary patch over the myocardial infarct (58) or injecting materials to thicken the ventricle wall (59) have proved successful to combat the pathological remodeling observed following myocardial infarction. While there have been recent advances in engineering ventricle-like chambers using scaffolds and 3D bioprinting (22,(60)(61)(62), compared to our dyn-EHT these chambers are much more difficult to fabricate, require a relatively large number of cells to form, and must be connected to a complicated flow system with valves and pressure transducers in order to generate preload.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, to better mimic cardiac disease, pathological features are being introduced using hypoxia-induced apoptosis 6 , mechanical stress 49 , or varied cardiac cell ratios 50 . Recent examples have also demonstrated how the introduction of electrical barriers such as holes in healthy cardiac tissue, or fibroblast dense regions can disrupt action potential propagation 45,51 .…”
Section: D Bioprinting High-cell Density Tissue Models Through Direcmentioning
confidence: 99%
“…Despite the predictive power shown even with routine 2D models, it is clear that existing lines-or, more accurately, their current embodiment in tissue culture-do not suffice to model all possible phenotypes of concern. The many acknowledged shortcomings, which have been mitigated to date only partially, include morphology (lack of sarcomere organization, T-tubules, and the normal mitochondrial density), molecular profile (weak expression of maturation-associated genes and splicing isoforms), metabolism (glycolysis, not fatty acid oxidation), contractility (lower maximum contractile force), and electrophysiology (lesser action potential upstroke velocity and amplitude) [48][49][50][51][85][86][87][88][89][90][91][92][93][94][95] . For instance, by comparison to adult human hearts, commercially available hPSC-CMs were uniformly deficient in the expression of KCNJ2, with higher than normal expression of HCN4 and large line-to-line variations in the other ion channels and membrane transporters assayed (CACNA1C, KCNH2, KCNQ1, SLC8A1, ATP1A1, ATP2A2) 51 .…”
Section: Challenges and Prospectsmentioning
confidence: 99%
“…In another approach, transduction of the defectively expressed gene KCNJ2 has been applied to rescue the channel levels and promote aspects of fidelity directly 98 . More generally, however, the procedures of most proven value to enhance the maturity of hPSC-CMs include the use of 3D human engineered heart tissue (EHT), mechanical or electrical conditioning, and heart-on-chip technologies, advances discussed at length elsewhere [89][90][91][92][93][94][95] . The tissue engineering solutions to create more heart-like phenotypes in hPSC-CMs range in complexity from micropatterned 2D substrates to scaffolds, organoids, microfluidics, 3D bioprinting, and even the construction of hollow spheres.…”
Section: Challenges and Prospectsmentioning
confidence: 99%